(Q44923161)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15179540%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15179540%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15179540%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

David Rott

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15179540%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Alan I Green

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15179540%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Daniel D Langleben

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15179540%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Scott E Lukas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15179540%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

David S Goldstein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15179540%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Alan Breier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15179540%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

4 June 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15179540%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

number of pages

7

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15179540%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15179540%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15179540%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

369-375

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15179540%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00213-004-1890-y

29 December 2019

exact match

0 references

cites work

Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-004-1890-Y

Postmortem studies in schizophrenia.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-004-1890-Y

Impaired Presynaptic Regulation of Norepinephrine in Schizophrenia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-004-1890-Y

Glucose metabolism in relation to schizophrenia and antipsychotic drug treatment

21 January 2018

1 reference

12 December 2020

Health and fitness series--1. The importance of physical activity for health

1 reference

12 December 2020

Diabetes mellitus in schizophrenic patients

1 reference

12 December 2020

Guanethidine blocks the 2-deoxy-D-glucose-induced hypothalamic noradrenergic drive to hyperglycemia.

1 reference

12 December 2020

Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia

1 reference

12 December 2020

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

1 reference

12 December 2020

The effect of 2-deoxy-D-glucose and D-glucose on the efferent discharge rate of sympathetic nerves

1 reference

12 December 2020

1 reference

12 December 2020

Physical consequences of schizophrenia and its treatment: the metabolic syndrome

1 reference

12 December 2020

Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

1 reference

12 December 2020

Antipsychotic medication: effects on regulation of glucose and lipids

1 reference

12 December 2020

Noradrenergic function in schizophrenia

1 reference

12 December 2020

Sympathetic control of hepatic glycogenolysis during glucopenia in man

1 reference

12 December 2020

Suppression of central noradrenergic neuronal activity inhibits hyperglycemia

1 reference

12 December 2020

The effect of pimozide on CSF norepinephrine in schizophrenia

1 reference

12 December 2020

The effects of pharmacological doses of 2-deoxyglucose on cerebral blood flow in healthy volunteers.

1 reference

12 December 2020

Relationships between brain noradrenergic activity and blood glucose

1 reference

12 December 2020

Possible Etiology of Schizophrenia: Progressive Damage to the Noradrenergic Reward System by 6-Hydroxydopamine

1 reference

12 December 2020

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

1 reference

12 December 2020

Increased noradrenaline levels in CSF and plasma of schizophrenic patients.

1 reference

12 December 2020

The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia

1 reference

12 December 2020

Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans

1 reference

12 December 2020

Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia

1 reference

12 December 2020

The relative importance of nervous system and hormones to the 2-deoxy-D-glucose-induced hyperglycemia in fed rats

1 reference

12 December 2020

A.E. Bennett award paper. Experimental approaches to human stress research: assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients.

1 reference

12 December 2020

CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal

1 reference

12 December 2020

The unhealthy lifestyle of people with schizophrenia

1 reference

12 December 2020

Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects.

1 reference

12 December 2020

Mechanism of peripheral noradrenergic stimulation by clozapine.

1 reference

12 December 2020

Plasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and nondeficit forms of schizophrenia

1 reference

12 December 2020

Novel glucosensor for hypoglycemic detection localized to the portal vein

1 reference

12 December 2020

The effect of norepinephrine on insulin secretion and glucose effectiveness in non-insulin-dependent diabetes.

1 reference

12 December 2020

Plasma norepinephrine in chronic schizophrenia

1 reference

12 December 2020

Interactions between insulin and norepinephrine on blood pressure and insulin sensitivity. Studies in lean and obese men

1 reference

12 December 2020

Measurements of plasma norepinephrine concentrations in human primary hypertension. A word of caution on their applicability for assessing neurogenic contributions

1 reference

12 December 2020

Effects of insulin on the counterregulatory response to equivalent hypoglycemia in normal females

1 reference

12 December 2020

Brain Norepinephrine and Dopamine in Schizophrenia

1 reference

12 December 2020

2-deoxy-D-glucose-induced hyperglycemia: role for direct sympathetic nervous system activation of liver glucose output

1 reference

12 December 2020

Dissociation of glucose and potassium arterial-venous differences across the forearm by acetazolamide. A possible relationship to acetazolamide's beneficial effect in hypokalemic periodic paralysis

1 reference

12 December 2020

Pancreatic noradrenergic nerves are activated by neuroglucopenia but not by hypotension or hypoxia in the dog. Evidence for stress-specific and regionally selective activation of the sympathetic nervous system

1 reference

12 December 2020

Schizophrenia: elevated cerebrospinal fluid norepinephrine

1 reference

12 December 2020

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics

1 reference

12 December 2020

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

1 reference

12 December 2020

Descending spinal pathways mediating the responses of adrenal tyrosine hydroxylase and catecholamines to insulin and 2-deoxyglucose.

1 reference

12 December 2020

The effects of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycemia in normal humans

1 reference

12 December 2020

Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine

1 reference

12 December 2020

Effects of weight loss on regional fat distribution and insulin sensitivity in obesity

1 reference

12 December 2020

Postmortem central catecholamines and antemortem cognitive impairment in elderly schizophrenics and controls.

1 reference

12 December 2020

Effects of hypothalamic stimulation and lesion on adrenal nerve activity.

1 reference

12 December 2020

Norepinephrine removal and release in the forearm of healthy subjects

1 reference

12 December 2020

Hypothalamic cholinergic activity associated with 2-deoxyglucose-induced hyperglycemia.

1 reference

12 December 2020

A twin study of mortality in schizophrenia and neurosis

1 reference

12 December 2020

Situational reactivity of autonomic functions in schizophrenic patients.

1 reference

12 December 2020

Impaired presynaptic regulation of norepinephrine in schizophrenia. Effects of clonidine in schizophrenic patients and normal controls

1 reference

12 December 2020

Sympathetic nervous system and insulin resistance: from obesity to diabetes

1 reference

12 December 2020

Juvenile onset diabetes and schizophrenia?

1 reference

12 December 2020

Hypothalamic cholinergic and noradrenergic neurons in hyperglycemia induced by 2-deoxyglucose

1 reference

12 December 2020

Enzymic and cerebral metabolic effects of 2-deoxy-D-glucose

1 reference

12 December 2020

Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients

1 reference

12 December 2020

Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

1 reference

12 December 2020

Hypothalamic noradrenergic and sympathoadrenal control of glycemia after stress

1 reference

12 December 2020

Plasma levels of catecholamines and corticotrophin during acute glucopenia induced by 2-deoxy-D-glucose in normal man

1 reference

12 December 2020

Octreotide-induced suppression of the hyperglycemic response to neostigmine or bombesin: relationship to hypothalamic noradrenergic drive

1 reference

12 December 2020

Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance.

1 reference

12 December 2020

Prevalence and correlates of diabetes in national schizophrenia samples.

1 reference

12 December 2020

The interface of psychiatric disorders and diabetes mellitus

1 reference

12 December 2020